Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology

Laura Sartiani1, Maria Novella Romanelli, Alessandro Mugelli

  • 1Department of NeuroFarBa, C.I.M.M.B.A., University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy. laura.sartiani@unifi.it.

Insights

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are crucial for heart rhythm. Dysfunction in these cardiac channels can cause arrhythmias, but blockade with ivabradine shows therapeutic potential.

Area of Science:

  • Cardiovascular physiology
  • Molecular cardiology
  • Ion channel research

Background:

  • Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are key to cardiac pacemaker activity.
  • HCN channels are present in various cardiac cells, with roles in adult cardiomyocytes under investigation.
  • Channel dysfunction is implicated in cardiac rhythm disorders.

Purpose of the Study:

  • To investigate the role of HCN channels in cardiac function and pathology.
  • To explore the therapeutic potential of modulating HCN channel activity.

Main Methods:

  • Review of literature on HCN channel function in cardiac physiology and pathology.
  • Analysis of clinical and experimental data regarding HCN channel mutations and pharmacological interventions.

Main Results:

  • Loss-of-function mutations in HCN channels are linked to sinus bradycardia.
  • Gain-of-function in HCN channels may promote arrhythmias like atrial fibrillation and ventricular hypertrophy.
  • Ivabradine, an HCN channel blocker, improves cardiac performance and outcomes in heart failure.

Conclusions:

  • HCN channels are critical determinants of cardiac rhythm.
  • Targeting HCN channels, particularly with ivabradine, offers a promising therapeutic strategy for cardiac arrhythmias and heart failure.
  • Development of novel, selective HCN channel modulators is ongoing.

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
7.4K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.2K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.9K
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
9.8K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
13.7K